Obserwuj
Morales-Briceño Hugo
Morales-Briceño Hugo
MD, FRACP
Zweryfikowany adres z health.nsw.gov.au
Tytuł
Cytowane przez
Cytowane przez
Rok
KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation
L Cif, D Demailly, JP Lin, KE Barwick, M Sa, L Abela, S Malhotra, ...
Brain 143 (11), 3242-3261, 2020
682020
Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypes
KR Kumar, RL Davis, MC Tchan, GM Wali, N Mahant, K Ng, K Kotschet, ...
Parkinsonism & related disorders 69, 111-118, 2019
522019
Overweight is more prevalent in patients with Parkinson's disease
H Morales-Briceño, A Cervantes-Arriaga, M Rodríguez-Violante, ...
Arquivos de neuro-psiquiatria 70, 843-846, 2012
482012
Clinical determinants of health-related quality of life in Mexican patients with Parkinson’s disease
M Rodríguez-Violante, A Cervantes-Arriaga, T Corona, ...
Archives of Medical Research 44 (2), 110-114, 2013
472013
Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence
H Morales-Briceño, SS Mohammad, B Post, AF Fois, RC Dale, M Tchan, ...
Brain 143 (3), 751-770, 2020
362020
Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation
HF Jones, H Morales-Briceño, K Barwick, J Lewis, A Sanchis-Juan, ...
Movement disorders: official journal of the Movement Disorder Society 34 (7 …, 2019
342019
Comparing the accuracy of different smell identification tests in Parkinson’s disease: relevance of cultural aspects
M Rodríguez-Violante, P Gonzalez-Latapi, A Camacho-Ordoñez, ...
Clinical neurology and neurosurgery 123, 9-14, 2014
332014
Diagnóstico premotor de la enfermedad de Parkinson
H Morales-Briceño, A Cervantes-Arriaga, M Rodríguez-Violante
Gaceta médica de México 147 (1), 22-32, 2011
332011
Caracterización de la enfermedad de Parkinson en México: estudio ReMePARK
A Cervantes-Arriaga, M Rodríguez-Violante, M López-Ruiz, ...
Gaceta médica de México 149 (5), 497-501, 2013
322013
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
B Cruse, H Morales-Briceño, FCF Chang, N Mahant, AD Ha, SD Kim, ...
npj Parkinson's Disease 4 (1), 34, 2018
282018
IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease
H Morales-Briceño, B Cruse, AF Fois, MW Lin, J Jiang, D Banerjee, ...
Neurology 90 (24), 1113-1115, 2018
282018
Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction
H Morales-Briceño, AD Ha, K London, D Farlow, FCF Chang, VSC Fung
Parkinsonism & Related Disorders 64, 319-323, 2019
272019
Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders
SS Mohammad, RR Angiti, A Biggin, H Morales-Briceño, R Goetti, ...
Brain Communications 2 (2), fcaa178, 2020
262020
The initial diagnosis and management of Parkinson's disease
S Waller, L Williams, H Morales-Briceno, VSC Fung
Australian journal of general practice 50 (11), 793-890, 2021
242021
Low specificity and sensitivity of smell identification testing for the diagnosis of Parkinson’s disease
M Rodríguez-Violante, P Gonzalez-Latapi, A Camacho-Ordoñez, ...
Arquivos de Neuro-psiquiatria 72, 33-37, 2014
212014
Clinical, imaging, and molecular findings in a sample of Mexican families with pantothenate kinase‐associated neurodegeneration
H Morales‐Briceño, OF Chacón‐Camacho, EA Pérez‐González, ...
Clinical genetics 87 (3), 259-265, 2015
162015
Parkinsonism and dystonia: clinical spectrum and diagnostic clues
H Morales-Briceno, VSC Fung, KP Bhatia, B Balint
Journal of the Neurological Sciences 433, 120016, 2022
122022
Paroxysmal dyskinesias with drowsiness and thalamic lesions in GABA transaminase deficiency
H Morales-Briceño, FCF Chang, C Wong, A Mallawaarachchi, N Wolfe, ...
Neurology 92 (2), 94-97, 2019
122019
Frequency and clinical correlates of postural and striatal deformities in Parkinson’s disease
A Cervantes-Arriaga, M Rodríguez-Violante, H Morales-Briceño, ...
Clinical Neurology and Neurosurgery 142, 140-144, 2016
112016
Encefalopatía mitocondrial, acidosis láctica y episodios stroke like (MELAS)
DA Espinoza-López, ES Vargas-Cañas, A Díaz-Alba, H Morales-Briceño, ...
Arch Neurocien (Mex) 17 (2), 138-41, 2012
112012
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20